- Home
- NWE vs DYN Comparison
NWE vs DYN Comparison
Compare NWE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWE | DYN |
|---|---|---|
| Founded | 1923 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.9B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NWE | DYN |
|---|---|---|
| Price | $72.51 | $24.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $66.50 | $37.00 |
| AVG Volume (30 Days) | 353.7K | ★ 2.6M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $1,610,559,000.00 | N/A |
| Revenue This Year | $8.84 | N/A |
| Revenue Next Year | $5.31 | N/A |
| P/E Ratio | $70.44 | ★ N/A |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $51.99 | $8.88 |
| 52 Week High | $75.18 | $25.00 |
Technical Indicators
Market Signals| Indicator | NWE | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 63.30 |
| Support Level | $69.08 | $16.47 |
| Resistance Level | $74.21 | $24.52 |
| Average True Range (ATR) | 1.47 | 1.46 |
| MACD | 0.03 | -0.11 |
| Stochastic Oscillator | 61.19 | 84.68 |
Price Performance
Historical ComparisonAbout NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric, which includes the generation, purchase, transmission, and distribution of electricity, and Natural Gas, which includes the production, purchase, transmission, storage, and distribution of natural gas. It uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.